Cervical Cancer Screening CDS for OpenMRS
0.1.0 - ci-build
Cervical Cancer Screening CDS for OpenMRS
0.1.0 - ci-build
Cervical Cancer Screening CDS for OpenMRS, published by Hopena Health. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/dhes/cervical-cancer-cds/tree/main and changes regularly. See the Directory of published versions
| Draft as of 2026-03-08 |
{
"resourceType" : "PlanDefinition",
"id" : "CervicalCancerTreatment",
"text" : {
"status" : "extensions",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b style=\"color: maroon\">Exception generating Narrative: unexpected non-end of element null::a at line 166 column 55</b></p></div>"
},
"url" : "https://hopenahealth.com/fhir/cervical-cancer-cds/PlanDefinition/CervicalCancerTreatment",
"version" : "0.1.0",
"name" : "CervicalCancerTreatment",
"title" : "Cervical Cancer Treatment — Ablation Eligibility and Modality Selection",
"type" : {
"coding" : [
{
"system" : "http://terminology.hl7.org/CodeSystem/plan-definition-type",
"code" : "eca-rule",
"display" : "ECA Rule"
}
]
},
"status" : "draft",
"experimental" : true,
"date" : "2026-03-08",
"publisher" : "Hopena Health",
"contact" : [
{
"name" : "Hopena Health",
"telecom" : [
{
"system" : "url",
"value" : "https://hopenahealth.com"
}
]
},
{
"name" : "Dan Heslinga",
"telecom" : [
{
"system" : "url",
"value" : "https://hopenahealth.com"
}
]
}
],
"description" : "Clinical decision support rule for treatment of cervical pre-cancer lesions. Implements WHO ablation eligibility criteria and treatment modality selection. Presents the clinician with a point-of-care ablation eligibility checklist (transformation zone type, lesion extent, suspicion of cancer) and recommends thermal ablation, cryotherapy, or excision (LEEP/LLETZ) based on eligibility and available data.",
"useContext" : [
{
"code" : {
"system" : "http://terminology.hl7.org/CodeSystem/usage-context-type",
"code" : "focus",
"display" : "Clinical Focus"
},
"valueCodeableConcept" : {
"coding" : [
{
"system" : "http://snomed.info/sct",
"code" : "1287592000",
"display" : "Thermocauterization of cervix"
}
]
}
}
],
"jurisdiction" : [
{
"coding" : [
{
"system" : "http://unstats.un.org/unsd/methods/m49/m49.htm",
"code" : "001"
}
]
}
],
"purpose" : "To guide treatment modality selection for women with HPV-positive, VIA-positive cervical pre-cancer, ensuring appropriate assessment of ablation eligibility and selection of the most suitable treatment method for the clinical setting.",
"copyright" : "Copyright 2026 Hopena Health. License: Apache 2.0",
"relatedArtifact" : [
{
"type" : "derived-from",
"label" : "WHO Guideline",
"display" : "WHO guideline for screening and treatment of cervical pre-cancer lesions for cervical cancer prevention, 2nd edition (2021)",
"url" : "https://www.who.int/publications/i/item/9789240030824",
"document" : {
"url" : "https://www.who.int/publications/i/item/9789240030824"
}
},
{
"type" : "citation",
"label" : "WHO Guidance",
"display" : "Ablation eligibility criteria: TZ type assessment, lesion extent, suspicion of cancer. Treatment preference: thermal ablation > cryotherapy > LEEP/LLETZ.",
"url" : "https://www.who.int/publications/i/item/9789240030824",
"document" : {
"url" : "https://www.who.int/publications/i/item/9789240030824"
}
},
{
"type" : "composed-of",
"display" : "Upstream: Triage routes VIA+ patients to treatment assessment",
"resource" : "https://hopenahealth.com/fhir/cervical-cancer-cds/PlanDefinition/CervicalCancerTriage|0.1.0"
},
{
"type" : "composed-of",
"display" : "Downstream: Treated patients enter post-treatment follow-up",
"resource" : "https://hopenahealth.com/fhir/cervical-cancer-cds/PlanDefinition/CervicalCancerFollowUp|0.1.0"
}
],
"library" : [
🔗 "https://hopenahealth.com/fhir/cervical-cancer-cds/Library/CervicalCancerTreatmentDecision|0.1.0"
],
"action" : [
{
"title" : "Treatment Assessment",
"description" : "Evaluate treatment indication and determine appropriate modality for cervical pre-cancer",
"trigger" : [
{
"type" : "named-event",
"name" : "patient-view"
}
],
"condition" : [
{
"kind" : "applicability",
"expression" : {
"language" : "text/cql-identifier",
"expression" : "Treatment Is Indicated",
"reference" : "Library/CervicalCancerTreatmentDecision"
}
}
],
"action" : [
{
"id" : "ablation-assessment",
"title" : "Assess Ablation Eligibility",
"description" : "Present ablation eligibility checklist for point-of-care clinical assessment. Ablation eligibility requires: (1) no suspicion of invasive/glandular disease, (2) TZ fully visible (Type 1 or 2), (3) lesion within probe reach.",
"condition" : [
{
"kind" : "applicability",
"expression" : {
"language" : "text/cql-identifier",
"expression" : "Treatment Is Indicated",
"reference" : "Library/CervicalCancerTreatmentDecision"
}
}
],
"type" : {
"coding" : [
{
"system" : "http://terminology.hl7.org/CodeSystem/action-type",
"code" : "create"
}
]
},
"dynamicValue" : [
{
"path" : "payload[0].contentString",
"expression" : {
"language" : "text/cql-identifier",
"expression" : "Ablation Eligibility Checklist",
"reference" : "Library/CervicalCancerTreatmentDecision"
}
},
{
"path" : "payload[1].contentString",
"expression" : {
"language" : "text/cql-identifier",
"expression" : "Treatment Recommendation",
"reference" : "Library/CervicalCancerTreatmentDecision"
}
}
]
},
{
"id" : "contraindication-alert",
"title" : "Ablation Contraindicated",
"description" : "Known contraindication to ablation — recommend excision (LEEP/LLETZ)",
"priority" : "urgent",
"condition" : [
{
"kind" : "applicability",
"expression" : {
"language" : "text/cql-identifier",
"expression" : "Has Known Contraindication To Ablation",
"reference" : "Library/CervicalCancerTreatmentDecision"
}
}
],
"type" : {
"coding" : [
{
"system" : "http://terminology.hl7.org/CodeSystem/action-type",
"code" : "create"
}
]
},
"dynamicValue" : [
{
"path" : "payload[0].contentString",
"expression" : {
"language" : "text/cql-identifier",
"expression" : "Treatment Recommendation",
"reference" : "Library/CervicalCancerTreatmentDecision"
}
}
]
},
{
"id" : "cin2-consideration",
"title" : "CIN2+ Diagnosed — Consider Excision",
"description" : "Patient has CIN2 or higher diagnosis — excision may be preferred even if TZ is ablation-eligible",
"condition" : [
{
"kind" : "applicability",
"expression" : {
"language" : "text/cql-identifier",
"expression" : "Has CIN2 Or Higher Diagnosis",
"reference" : "Library/CervicalCancerTreatmentDecision"
}
}
],
"type" : {
"coding" : [
{
"system" : "http://terminology.hl7.org/CodeSystem/action-type",
"code" : "create"
}
]
},
"dynamicValue" : [
{
"path" : "payload[0].contentString",
"expression" : {
"language" : "text/cql-identifier",
"expression" : "Treatment Recommendation",
"reference" : "Library/CervicalCancerTreatmentDecision"
}
}
]
},
{
"id" : "refer-oncology",
"title" : "Cervical Cancer — Refer to Oncology",
"description" : "Patient has cervical cancer diagnosis — refer for oncology management, not screening pathway treatment",
"priority" : "urgent",
"condition" : [
{
"kind" : "applicability",
"expression" : {
"language" : "text/cql-identifier",
"expression" : "Has Known Contraindication To Ablation",
"reference" : "Library/CervicalCancerTreatmentDecision"
}
}
],
"type" : {
"coding" : [
{
"system" : "http://terminology.hl7.org/CodeSystem/action-type",
"code" : "create"
}
]
},
"dynamicValue" : [
{
"path" : "payload[0].contentString",
"expression" : {
"language" : "text/cql-identifier",
"expression" : "Treatment Recommendation",
"reference" : "Library/CervicalCancerTreatmentDecision"
}
}
]
}
]
}
]
}